Sheikh Mohammed Shariful Islam

Sheikh Mohammed Shariful Islam, Moloud Abrar, Teketo Tegegne et al.

Machine learning models have the potential to identify cardiovascular diseases (CVDs) early and accurately in primary healthcare settings, which is crucial for delivering timely treatment and management. Although population-based CVD risk models have been used traditionally, these models often do not consider variations in lifestyles, socioeconomic conditions, or genetic predispositions. Therefore, we aimed to develop machine learning models for CVD detection using primary healthcare data, compare the performance of different models, and identify the best models. We used data from the UK Biobank study, which included over 500,000 middle-aged participants from different primary healthcare centers in the UK. Data collected at baseline (2006--2010) and during imaging visits after 2014 were used in this study. Baseline characteristics, including sex, age, and the Townsend Deprivation Index, were included. Participants were classified as having CVD if they reported at least one of the following conditions: heart attack, angina, stroke, or high blood pressure. Cardiac imaging data such as electrocardiogram and echocardiography data, including left ventricular size and function, cardiac output, and stroke volume, were also used. We used 9 machine learning models (LSVM, RBFSVM, GP, DT, RF, NN, AdaBoost, NB, and QDA), which are explainable and easily interpretable. We reported the accuracy, precision, recall, and F-1 scores; confusion matrices; and area under the curve (AUC) curves.

Yasin Sadeghi Bazargani, Majid Mirzaei, Navid Sobhi et al.

Diabetes mellitus (DM) predisposes patients to vascular complications. Retinal images and vasculature reflect the body's micro- and macrovascular health. They can be used to diagnose DM complications, including diabetic retinopathy (DR), neuropathy, nephropathy, and atherosclerotic cardiovascular disease, as well as forecast the risk of cardiovascular events. Artificial intelligence (AI)-enabled systems developed for high-throughput detection of DR using digitized retinal images have become clinically adopted. Beyond DR screening, AI integration also holds immense potential to address challenges associated with the holistic care of the patient with DM. In this work, we aim to comprehensively review the literature for studies on AI applications based on retinal images related to DM diagnosis, prognostication, and management. We will describe the findings of holistic AI-assisted diabetes care, including but not limited to DR screening, and discuss barriers to implementing such systems, including issues concerning ethics, data privacy, equitable access, and explainability. With the ability to evaluate the patient's health status vis a vis DM complication as well as risk prognostication of future cardiovascular complications, AI-assisted retinal image analysis has the potential to become a central tool for modern personalized medicine in patients with DM.

Fahime Khozeimeh, Danial Sharifrazi, Navid Hoseini Izadi et al.

COVID-19 has caused many deaths worldwide. The automation of the diagnosis of this virus is highly desired. Convolutional neural networks (CNNs) have shown outstanding classification performance on image datasets. To date, it appears that COVID computer-aided diagnosis systems based on CNNs and clinical information have not yet been analysed or explored. We propose a novel method, named the CNN-AE, to predict the survival chance of COVID-19 patients using a CNN trained with clinical information. Notably, the required resources to prepare CT images are expensive and limited compared to those required to collect clinical data, such as blood pressure, liver disease, etc. We evaluated our method using a publicly available clinical dataset that we collected. The dataset properties were carefully analysed to extract important features and compute the correlations of features. A data augmentation procedure based on autoencoders (AEs) was proposed to balance the dataset. The experimental results revealed that the average accuracy of the CNN-AE (96.05%) was higher than that of the CNN (92.49%). To demonstrate the generality of our augmentation method, we trained some existing mortality risk prediction methods on our dataset (with and without data augmentation) and compared their performances. We also evaluated our method using another dataset for further generality verification. To show that clinical data can be used for COVID-19 survival chance prediction, the CNN-AE was compared with multiple pre-trained deep models that were tuned based on CT images.

Danial Sharifrazi, Roohallah Alizadehsani, Mohamad Roshanzamir et al.

The coronavirus (COVID-19) is currently the most common contagious disease which is prevalent all over the world. The main challenge of this disease is the primary diagnosis to prevent secondary infections and its spread from one person to another. Therefore, it is essential to use an automatic diagnosis system along with clinical procedures for the rapid diagnosis of COVID-19 to prevent its spread. Artificial intelligence techniques using computed tomography (CT) images of the lungs and chest radiography have the potential to obtain high diagnostic performance for Covid-19 diagnosis. In this study, a fusion of convolutional neural network (CNN), support vector machine (SVM), and Sobel filter is proposed to detect COVID-19 using X-ray images. A new X-ray image dataset was collected and subjected to high pass filter using a Sobel filter to obtain the edges of the images. Then these images are fed to CNN deep learning model followed by SVM classifier with ten-fold cross validation strategy. This method is designed so that it can learn with not many data. Our results show that the proposed CNN-SVM with Sobel filtering (CNN-SVM+Sobel) achieved the highest classification accuracy of 99.02% in accurate detection of COVID-19. It showed that using Sobel filter can improve the performance of CNN. Unlike most of the other researches, this method does not use a pre-trained network. We have also validated our developed model using six public databases and obtained the highest performance. Hence, our developed model is ready for clinical application

Roohallah Alizadehsani, Danial Sharifrazi, Navid Hoseini Izadi et al.

The new coronavirus has caused more than one million deaths and continues to spread rapidly. This virus targets the lungs, causing respiratory distress which can be mild or severe. The X-ray or computed tomography (CT) images of lungs can reveal whether the patient is infected with COVID-19 or not. Many researchers are trying to improve COVID-19 detection using artificial intelligence. Our motivation is to develop an automatic method that can cope with scenarios in which preparing labeled data is time consuming or expensive. In this article, we propose a Semi-supervised Classification using Limited Labeled Data (SCLLD) relying on Sobel edge detection and Generative Adversarial Networks (GANs) to automate the COVID-19 diagnosis. The GAN discriminator output is a probabilistic value which is used for classification in this work. The proposed system is trained using 10,000 CT scans collected from Omid Hospital, whereas a public dataset is also used for validating our system. The proposed method is compared with other state-of-the-art supervised methods such as Gaussian processes. To the best of our knowledge, this is the first time a semi-supervised method for COVID-19 detection is presented. Our system is capable of learning from a mixture of limited labeled and unlabeled data where supervised learners fail due to a lack of sufficient amount of labeled data. Thus, our semi-supervised training method significantly outperforms the supervised training of Convolutional Neural Network (CNN) when labeled training data is scarce. The 95% confidence intervals for our method in terms of accuracy, sensitivity, and specificity are 99.56 +- 0.20%, 99.88 +- 0.24%, and 99.40 +- 0.18%, respectively, whereas intervals for the CNN (trained supervised) are 68.34 +- 4.11%, 91.2 +- 6.15%, and 46.40 +- 5.21%.

Sakifa Aktar, Md. Martuza Ahamad, Md. Rashed-Al-Mahfuz et al.

Introduction: For COVID-19 patients accurate prediction of disease severity and mortality risk would greatly improve care delivery and resource allocation. There are many patient-related factors, such as pre-existing comorbidities that affect disease severity. Since rapid automated profiling of peripheral blood samples is widely available, we investigated how such data from the peripheral blood of COVID-19 patients might be used to predict clinical outcomes. Methods: We thus investigated such clinical datasets from COVID-19 patients with known outcomes by combining statistical comparison and correlation methods with machine learning algorithms; the latter included decision tree, random forest, variants of gradient boosting machine, support vector machine, K-nearest neighbour and deep learning methods. Results: Our work revealed several clinical parameters measurable in blood samples, which discriminated between healthy people and COVID-19 positive patients and showed predictive value for later severity of COVID-19 symptoms. We thus developed a number of analytic methods that showed accuracy and precision for disease severity and mortality outcome predictions that were above 90%. Conclusions: In sum, we developed methodologies to analyse patient routine clinical data which enables more accurate prediction of COVID-19 patient outcomes. This type of approaches could, by employing standard hospital laboratory analyses of patient blood, be utilised to identify, COVID-19 patients at high risk of mortality and so enable their treatment to be optimised.